Benzinga's Top #PreMarket Losers
March 09, 2015 at 08:17 AM EDT
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares fell 46.11% to $4.71 in pre-market trading. AcelRx received an FDA update regarding ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.